AssayIndex
Supplier records

Every HYB record · page 6

Every HYB record the index holds, newest first. Sort any column. The rollups are on the scorecard; this is the underlying evidence. Shenzhen Hybio Pharmaceutical Co., Ltd. sells direct at hybiopharmaceutical.com →.

332 recordsmedian 99.45 %9 pagesupdated 30 Jul 2026
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019102BPC-157HYB-2502-R3188PeptideMeter2025-Q199.854.9197.1Buyer-sourced1FAIL
AX-2025-019118TirzepatideHYB-2408-R4018Medutest2025-Q198.084.9398.4Buyer-sourced0PASS
AX-2025-019094BPC-157HYB-2502-R3188Janoshik2025-Q199.635.9098.6Buyer-sourced1FAIL
AX-2025-019127GHRP-2HYB-2501-R4243Janoshik2025-Q199.554.66—Buyer-sourced1MARGINAL
AX-2025-019093BPC-157HYB-2502-R3188Medutest2025-Q199.695.32—Buyer-sourced0PASS
AX-2025-019182TB-500HYB-2410-J4560Janoshik2025-Q199.585.42104.4Buyer-sourced0PASS
AX-2025-019121GHRP-2HYB-2501-R4243Janoshik2025-Q199.645.7397.0Buyer-sourced1MARGINAL
AX-2025-019116TirzepatideHYB-2408-R4018PeptideMeter2025-Q198.135.3089.7Buyer-sourced1MARGINAL
AX-2025-019126GHRP-2HYB-2501-R4243PeptideMeter2025-Q199.934.8794.9Laboratory-retained1MARGINAL
AX-2025-019183TB-500HYB-2410-J4560Medutest2025-Q199.935.85—Buyer-sourced0PASS
AX-2025-019089TirzepatideHYB-2408-W3304Nordanalyt2025-Q199.044.17—Buyer-sourced0PASS
AX-2025-019120GHRP-2HYB-2501-R4243Janoshik2025-Q199.664.7891.2Buyer-sourced2MARGINAL
AX-2025-019083TirzepatideHYB-2408-W3304Nordanalyt2025-Q198.734.34—Buyer-sourced0PASS
AX-2025-019112TirzepatideHYB-2408-R4018Janoshik2025-Q198.275.75103.7Laboratory-retained0PASS
AX-2025-019113TirzepatideHYB-2408-R4018Janoshik2025-Q198.465.6690.0Buyer-sourced0PASS
AX-2025-019115TirzepatideHYB-2408-R4018Janoshik2025-Q198.195.4290.6Buyer-sourced0PASS
AX-2025-019111TirzepatideHYB-2408-R4018Kestrel2025-Q198.915.82—Buyer-sourced0PASS
AX-2025-019085TirzepatideHYB-2408-W3304Medutest2025-Q199.194.86—Buyer-sourced0PASS
AX-2025-019181TB-500HYB-2410-J4560PeptideMeter2025-Q199.695.47—Buyer-sourced0PASS
AX-2025-019114TirzepatideHYB-2408-R4018Janoshik2025-Q198.085.4588.6Buyer-sourced1MARGINAL
AX-2025-019109TirzepatideHYB-2408-R4018VendorInvestigate2025-Q198.554.9689.9Buyer-sourced1MARGINAL
AX-2025-019100BPC-157HYB-2502-R3188Janoshik2025-Q199.855.16107.2Buyer-sourced0PASS
AX-2025-019098BPC-157HYB-2502-R3188PeptideMeter2025-Q199.565.3288.6Buyer-sourced1MARGINAL
AX-2025-019097BPC-157HYB-2502-R3188Janoshik2025-Q199.594.77—Buyer-sourced0PASS
AX-2025-019087TirzepatideHYB-2408-W3304Janoshik2025-Q199.194.29103.5Buyer-sourced0PASS
AX-2025-019103BPC-157HYB-2502-R3188VendorInvestigate2025-Q199.825.1297.1Buyer-sourced0PASS
AX-2025-019117TirzepatideHYB-2408-R4018Janoshik2025-Q198.545.6393.5Buyer-sourced0PASS
AX-2025-019092TirzepatideHYB-2408-W3304Nordanalyt2025-Q199.154.82—Buyer-sourced0PASS
AX-2025-019110TirzepatideHYB-2408-R4018Janoshik2025-Q198.305.55—Buyer-sourced0PASS
AX-2025-019091TirzepatideHYB-2408-W3304Kestrel2025-Q199.934.8793.6Buyer-sourced0PASS
AX-2025-019104SemaglutideHYB-2407-V3438Janoshik2024-Q498.934.29105.3Buyer-sourced0PASS
AX-2024-004653Enclomiphene citrateHYB-2408-N4134Janoshik2024-Q499.932.35—Buyer-sourced0FAIL
AX-2024-004582BPC-157HYB-2409-X3064Nordanalyt2024-Q498.403.8192.5Buyer-sourced1MARGINAL
AX-2024-004590SemaglutideHYB-2407-V3438Medutest2024-Q498.304.31—Buyer-sourced0PASS
AX-2024-004586BPC-157HYB-2409-X3064Medutest2024-Q498.813.96—Buyer-sourced2FAIL
AX-2024-004656Enclomiphene citrateHYB-2408-N4134Janoshik2024-Q499.902.36102.6Buyer-sourced0FAIL
AX-2024-004588BPC-157HYB-2409-X3064Janoshik2024-Q498.503.71—Buyer-sourced1MARGINAL
AX-2024-004581BPC-157HYB-2409-X3064Nordanalyt2024-Q498.503.63102.5Buyer-sourced1MARGINAL
AX-2024-004589BPC-157HYB-2409-X3064Janoshik2024-Q498.433.59104.2Buyer-sourced1MARGINAL
AX-2024-004584BPC-157HYB-2409-X3064Janoshik2024-Q498.483.94105.9Buyer-sourced1MARGINAL